Beyond SBIRs: The NIH as a Technology Development and Commercialization Partner
How companies can partner with the NIH to bolster their pipeline or solve development problems through business models with highly competitive financial terms regarding equity, royalty costs and overhead rates.
Registration is complimentary and required to attend.
About this Webinar:
The National Institutes of Health (NIH), the world’s largest biomedical research institute, could bring value to your biotech in ways you are likely unaware. In this webinar, we will discuss how companies, entrepreneurs and other buy-side stakeholders can partner with the NIH to bolster their pipeline or solve development problems. The NIH works with companies to positively impact their chances as an equity investment, M&A target, or active employer.
Key takeaways:
How the NIH can help biotechs to solve pipeline or development problems
Partnership models beyond academic/basic research and SBIRs
Success stories and partnership examples
Points of contact, partnering mechanisms and licensing
Registration is complimentary and required to attend.